Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Pediatric Infection and Vaccine is Scopus-indexed (Q4, CiteScore 0.5). Published by The Korean Society of Pediatric Infectious Diseases.
Checked against the index lists dated .
ISSN 2384-1079Verify ISSN ↗2384-1087Verify ISSN ↗
Publisher: The Korean Society of Pediatric Infectious Diseases
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pediatrics, Perinatology and Child Health | 288 / 351 | 18th | Q4 |
| Infectious Diseases | 327 / 361 | 9th | Q4 |
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2015–2024, best quartile Q4, CiteScore 0.5.
Pediatric Infection and Vaccine is Q4 in Pediatrics, Perinatology and Child Health (rank 288 of 351) and Q4 in Infectious Diseases (rank 327 of 361), by CiteScore 2025.
Pediatric Infection and Vaccine is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 0.5, quartile Q4, 18th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.131, quartile Q4, with an H-index of 6.
Pediatric Infection and Vaccine is published by The Korean Society of Pediatric Infectious Diseases. Its print ISSN is 2384-1079 and its online ISSN is 2384-1087.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
No — it is not registered as an open-access journal in DOAJ or Scopus.
Pediatric Infection and Vaccine has an h-index of 10 and a 2-year mean of 0.83 citations per paper (OpenAlex). Its Scopus CiteScore is 0.5, quartile Q4. On 2-year citations it ranks #190 of 344 Scopus journals in Pediatrics, Perinatology and Child Health.
Pediatric Infection and Vaccine published 18 papers in 2024; its busiest recent year was 2015 with 42. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 84 research articles (2021–2024), authors are most often from South Korea (95.8%), Malaysia (1.2%) and Iran (1.2%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.